Tags: Drug.
Lerdelimumab (CAT-152 intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results.
Loading...
This page contains content from the copyrighted Wikipedia article "Lerdelimumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.